Sanofi’s Rezurock accepted in Scotland
Therapy treats patients with chronic graft-versus-host disease who have already received other treatments
Read More
Tag: Sanofi
Sanofi announces positive data for frexalimab in relapsing MS
The neurological disease affects approximately 2.8 million people worldwide
Read More
Sanofi releases AVAXIM Junior in the UK
Therapy provides immunisation against infection caused by hepatitis A in children aged 12 months to 15 years
Read More
Sanofi’s efanesoctocog alfa may be game-changer for haemophilia A patients
Phase 3 study demonstrated that efanesoctocog alfa met both primary and secondary endpoints
Read More
QiC Diabetes awards 2022 celebrate UK healthcare excellence
The annual awards recognise the efforts of NHS teams and individuals
Read More
CHMP recommends Sanofi and AstraZeneca’s Beyfortus to treat respiratory syncytial virus
Therapy has been developed for the prevention of disease in infants
Read More
Positive phase 3 data for Sanofi’s Dupixent
Research showed significant improvements in signs and symptoms of prurigo nodularis
Read More
Sanofi and Regeneron’s Dupixent shows consistent safety profile
Study involving children aged six to 11 years with moderate-to-severe asthma reveals positive data
Read More
Sanofi provides update on amcenestrant
The company’s clinical development programme is to be discontinued following a recent evaluation
Read More
Sanofi and Innovent Biologics enter strategic collaboration
Partnership will accelerate development of oncology medicines and expand presence in China
Read More
Sanofi and Regeneron’s Dupixent shows positive results in phase 3 trial
Trial focusing on children with eosinophilic oesophagitis has met its primary endpoint
Read More
Sanofi and Sobi present effective bleeding treatment
Data demonstrates that efanesoctocog alfa provides superior bleed protection
Read More
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
- NHS reduces long waits for cancer care and achieves faster ambulance responses
- MHRA’s AI Airlock to address challenges for regulating AI medical devices
